Nachrichten zur Intrexon Corp Aktie

Triple-Gene Presented Preliminary Phase 1 Trial Data of Investigational Multigenic Therapeutic Candidate INXN4001 for Treatment of Heart Failure at American Heart Association Annual Meeting

GERMANTOWN, Md. , Nov. 18, 2019 /PRNewswire/ --  Triple-Gene LLC …

Intrexon Corp (XON) CEO RJ Kirk on Precigen Inc Business and Pipeline Update Conference Call (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Intrexon down 3% on Q3 miss

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Intrexon EPS misses by $0.13, misses on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Intrexon Reports Third Quarter 2019 Financial Results

GERMANTOWN, Md. , Nov. 12, 2019 /PRNewswire/ --  Intrexon Corporation …

Intrexon Q3 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Triple-Gene Announces Completion of Enrollment and Dosing in Phase 1 Trial of INXN4001, First Multigenic Investigational Therapeutic Candidate for Treatment of Heart Failure

GERMANTOWN, Md. , Nov. 7, 2019 /PRNewswire/ -- Triple-Gene LLC …

Intrexon to Announce Third Quarter Financial Results on November 12th

GERMANTOWN, Md. , Nov. 4, 2019 /PRNewswire/ -- Intrexon Corporation …

Intrexon sells AquaBounty stake to CEO-affiliated aquaculture business

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

David H. Witte to lead MBP Titan LLC

GERMANTOWN, Md., Sept. 26, 2019 /PRNewswire/ -- Intrexon Corporation  (NASDAQ: XON), a leader…

Next Green Wave achieves operational milestones for Intrexons Botticelli cannabis plantlet production

Next Green Wave Holdings Inc (CSE:NGW) (OTCMKTS:NXGWF) said Tuesday that it has completed the installation and activation of its research…

DGAP-News: Next Green Wave

Next Green Wave Achieves Operational Milestones For Intrexons...…

Avoid The Intrexon Hype

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Intrexon Corp (XON) Q2 2019 Earnings Call Transcript

XON earnings call for the period ending June 30, 2019....…

Intrexon Corporation 2019 Q2 - Results - Earnings Call Slides

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Intrexon (XON) Reports Narrower-Than-Expected Loss in Q2

Intrexon (XON) posts a narrower-than-expected loss and misses sales estimates in the second quarter of 2019....…

Intrexon Corp (XON) CEO Randal Kirk on Q2 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Intrexon Reports Second Quarter and First Half 2019 Financial Results

GERMANTOWN, Md. , Aug. 8, 2019 /PRNewswire/ --  Intrexon Corporation …

Precigen Announces First Patient Dosed in Phase 1 Study of PRGN-3005 UltraCAR-T in Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer

GERMANTOWN, Md. , Aug. 5, 2019 /PRNewswire/ -- Precigen, Inc. …

Intrexon to Announce Second Quarter and First Half 2019 Financial Results on August 8th

GERMANTOWN, Md. , Aug. 1, 2019 /PRNewswire/ -- Intrexon Corporation …

Heres Why Intrexon Jumped 58% in June

The biotech is getting into the cannabinoids business....…

ActoBio Therapeutics Progresses AG019 to Next Stage of a Phase Ib/IIa Clinical Study for the Treatment of Type 1 Diabetes

GHENT, Belgium, July 1, 2019 /PRNewswire/ --   ActoBio Therapeutics, Inc. …

Precigen Announces First Patient Dosed in Phase 1/1b Study of PRGN-3006 UltraCAR-T in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or Higher Risk Myelodysplastic Syndrome (MDS)

GERMANTOWN, Md. , June 26, 2019 /PRNewswire/ -- Precigen, Inc., a wholly-owned subsidiary of Intrexon…

Do Options Traders Know Something About Intrexon (XON) Stock We Dont-

Investors need to pay close attention to Intrexon (XON) stock based on the movements in the options market lately....…

Intrexon Up on Striking 100M Cannabinoid Deal With Surterra

Intrexon (XON) inks a $100-million worth exclusive licensing deal with Surterra to produce cannabinoid in a reliable and cost-effective fashion,…

Why Intrexon Stock Popped Today

A big deal with a medical cannabis company provided a spark for Intrexon....…

Intrexon Strikes $100M Partnership With Surterra For Cannabinoid Production

Intrexon Corporation (NASDAQ: XON) announced a $100 million partnership with Surterra Wellness to advance its cannabinoid production. read more...…

Insider Weekends: Randal Kirk Buys Intrexon At Much Higher Prices

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Intrexon Corporation and Surterra Wellness Partner in $100mm Deal to Advance Commercial Scale Fermentation-based Cannabinoid Production

BUDAPEST, Hungary and ATLANTA , June 18, 2019 /PRNewswire/ -- Intrexon…

Intrexon CEO Made Big Open-Market Bets In May

Biotechnology company Intrexon Corp (NASDAQ: XON) CEO Randal Kirk made five bundles of large purchases of the companys stock over…

Insider Weekends: Randal Kirk Purchases Over $8 Million Of Intrexon

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Intrexon to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference

GERMANTOWN, Md. , May 13, 2019 /PRNewswire/ --  Intrexon Corporation …

Intrexon Reports First Quarter 2019 Financial Results

GERMANTOWN, Md. , May 9, 2019 /PRNewswire/ --  Intrexon Corporation …

Intrexon to Release First Quarter 2019 Financial Results on May 9th

GERMANTOWN, Md. , May 2, 2019 /PRNewswire/ --   …

Intrexon and Xogenex Present at American Society of Gene and Cell Therapy Annual Meeting

GERMANTOWN, Md. , April 29, 2019 /PRNewswire/ --  Intrexon Corporation …

Precigen Opens Gene and Cell Therapy Manufacturing Facility in Germantown, Maryland

GERMANTOWN, Md. , April 25, 2019 /PRNewswire/ -- Precigen, Inc., a wholly-owned subsidiary of Intrexon…

Intrexon to Highlight Microbial Cannabinoid Production Platform at the Paradigm Capital Biosynthesis Conference

GERMANTOWN, Md. , April 10, 2019 /PRNewswire/ --   …

Oxitec Advances Self-Limiting Fall Armyworm Control Solution to Next Phase of Development

OXFORD, England , April 9, 2019 /PRNewswire/ -- Oxitec Ltd., a wholly-owned subsidiary of Intrexon…

Why Intrexon Stock Dropped 34% in March

Investors werent happy to learn about its worsening cash position....…

Intrexon Intensifies Focus on Healthcare, Forms Two Units and Streamlines Management

GERMANTOWN, Md. , April 3, 2019 /PRNewswire/ -- Intrexon Corporation (NASDAQ: XON), announced today that…

Why Is Intrexon (XON) Down 34% Since Last Earnings Report-

Intrexon (XON) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Intrexon - The Opportunity Of A Lifetime - The Energy Assets

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Heres What Caused Intrexons 21% Rally Today

The company got welcome support from a big money manager....…

Heres Why Intrexon Crashed (Again) Today

The companys burning through cash, and that has investors nervous....…

Intrexon, Surterra Wellness Collaborate On Plant Propagation For Cannabis Cultivation

Intrexon Corporation (NASDAQ: XON) announced Monday that it entered a strategic licensing agreement with Surterra Wellness to utilize its plant…

Intrexon - The Opportunity Of A Lifetime - The Healthcare Assets And Pipeline

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Mid-Day Market Update: Puma Biotechnology Climbs Following Strong Q4 Results; Intrexon Shares Slide

Midway through trading Friday, the Dow traded down 0.01 percent to 25,914.55 while the NASDAQ climbed 0.12 percent to 7,541.22.…

Intrexon (XON) Reports Narrower-Than-Expected Loss in Q4

Intrexon (XON) incurs narrower-than-expected loss in the fourth quarter of 2018....…

Intrexon Corp (XON) Q4 2018 Earnings Conference Call Transcript

XON earnings call for the period ending December 31, 2018....…

Intrexon Corp (XON) Q4 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…